title: Response to fibrolamellar hepatocellular carcinoma versus conventional hepatocellular carcinoma: better 5-year survival or artefactual result of research methodology?
authors.affiliation: MOB, NIH, Bethesda, Maryland, USA.
authors.forename: Tobias
authors.initials: T
authors.lastname: Eggert
authors.affiliation: MOB, NIH, Bethesda, Maryland, USA.
authors.forename: Katherine
authors.initials: K
authors.lastname: McGlynn
authors.affiliation: NCI, Center for Cancer Research, Bethesda, Maryland, USA.
authors.forename: Tim F
authors.initials: TF
authors.lastname: Greten
authors.affiliation: NCI, Center for Cancer Research, Bethesda, Maryland, USA.
authors.forename: Sean
authors.initials: S
authors.lastname: Altekruse
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality*; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality*; D012107:Research Design
keywords: LIVER